Business Description
Y-Biologics Inc
ISIN : KR7338840002
Description
Y-Biologics Inc is a company has a variety of development candidate antibodies based on Korea's highest-level antibody discovery platform technology and then independently develops antibody treatments or jointly develops cutting-edge biopharmaceuticals by fusing them with our partner's platform technology. Its main business model is based on a globally competitive antibody discovery platform and consists of development of new bio drug candidates and early technology transfer, and contract research services that generate stable cash flow.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 19.96 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.05 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 11.68 | |||||
Beneish M-Score | -4.77 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 33.4 | |||||
3-Year EBITDA Growth Rate | -8.3 | |||||
3-Year EPS without NRI Growth Rate | -8.2 | |||||
3-Year FCF Growth Rate | 17.4 | |||||
3-Year Book Growth Rate | 9.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 56 | |||||
9-Day RSI | 56.36 | |||||
14-Day RSI | 55.48 | |||||
6-1 Month Momentum % | -42.7 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.05 | |||||
Quick Ratio | 6.05 | |||||
Cash Ratio | 5.66 | |||||
Days Sales Outstanding | 25.83 | |||||
Days Payable | 2.83 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9 | |||||
Shareholder Yield % | -8.86 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 76.67 | |||||
Operating Margin % | -208.41 | |||||
Net Margin % | -460.13 | |||||
FCF Margin % | -194.99 | |||||
ROE % | -130.27 | |||||
ROA % | -76.43 | |||||
ROIC % | -48.39 | |||||
ROC (Joel Greenblatt) % | -216.87 | |||||
ROCE % | -120.42 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 32.35 | |||||
PB Ratio | 6.67 | |||||
Price-to-Tangible-Book | 6.74 | |||||
EV-to-EBIT | -7.1 | |||||
EV-to-EBITDA | -7.76 | |||||
EV-to-Revenue | 32.57 | |||||
EV-to-FCF | -15.78 | |||||
Price-to-Net-Current-Asset-Value | 10.58 | |||||
Price-to-Net-Cash | 11.56 | |||||
Earnings Yield (Greenblatt) % | -14.11 | |||||
FCF Yield % | -5.33 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Y-Biologics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 4,077.165 | ||
EPS (TTM) (â‚©) | -1473 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 55.48 | ||
14-Day ATR (â‚©) | 718.364492 | ||
20-Day SMA (â‚©) | 9577 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (â‚©) | 8090 - 23800 | ||
Shares Outstanding (Mil) | 14.77 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Y-Biologics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Y-Biologics Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Y-Biologics Inc Frequently Asked Questions
What is Y-Biologics Inc(XKRX:338840)'s stock price today?
The current price of XKRX:338840 is â‚©10110.00. The 52 week high of XKRX:338840 is â‚©23800.00 and 52 week low is â‚©8090.00.
When is next earnings date of Y-Biologics Inc(XKRX:338840)?
The next earnings date of Y-Biologics Inc(XKRX:338840) is .
Does Y-Biologics Inc(XKRX:338840) pay dividends? If so, how much?
Y-Biologics Inc(XKRX:338840) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |